We are live on ! Find out more
PSC

Piper Sandler & Co Portfolio holdings

AUM $135M
1-Year Est. Return 0.15%
This Fund
S&P 500
This Quarter Est. Return
-3.6%
1 Year Est. Return
+0.15%
3 Year Est. Return
-0.04%
5 Year Est. Return
-7.65%
10 Year Est. Return
–
AUM
$93.5M
AUM Growth
-$73.3M
Cap. Flow
-$82.1M
Cap. Flow %
-87.75%
Top 10 Hldgs %
75.11%
Holding
169
New
71
Increased
4
Reduced
22
Closed
63

Top Buys

Rank Stock Value
1
VTVT icon
vTv Therapeutics
VTVT
+$6.75M
2
AMBA icon
Ambarella
AMBA
+$708K
3
EW icon
Edwards Lifesciences
EW
+$652K
4
LMNX
Luminex Corp
LMNX
+$624K
5
IBB icon
iShares Biotechnology ETF
IBB
+$576K

Top Sells

Rank Stock Value
1
OCR.PRB
OMNICARE CAP TR II SER B 4% TR PFD INCM EQTY REDM SEC PIERS
OCR.PRB
+$19.6M
2
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
+$2.75M
3
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
+$2.51M
4
TZA icon
Direxion Daily Small Cap Bear 3x ETF
TZA
+$1.31M
5
IMMR icon
Immersion
IMMR
+$919K

Sector Composition

Rank Sector Weight
1 Healthcare 15.55%
2 Technology 8.46%
3 Industrials 1.33%
4 Consumer Discretionary 1.27%
5 Communication Services 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTX
151
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-800
Closed -$47K
OUTR
152
DELISTED
OUTERWALL INC
OUTR
– –
-2,500
Closed -$190K
RLD
153
DELISTED
REALD INC COM STK
RLD
– –
-15,000
Closed -$185K
ADEP
154
DELISTED
Adept Technology Inc
ADEP
– –
-35,000
Closed -$252K
OCR.PRB
155
DELISTED
OMNICARE CAP TR II SER B 4% TR PFD INCM EQTY REDM SEC PIERS
OCR.PRB
– –
-169,500
Closed -$19.6M
CTRX
156
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
– –
-45,000
Closed -$2.75M
CY
157
DELISTED
Cypress Semiconductor
CY
– –
-25,000
Closed -$294K
KEY.PRG
158
DELISTED
KeyCorp Pfd
KEY.PRG
– –
-61
Closed -$8K
RKUS
159
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
– –
-50,000
Closed -$517K
VG
160
DELISTED
Vonage Holdings Corporation
VG
– –
-30,000
Closed -$147K
VXX
161
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
– –
-7,813
Closed -$2.51M
3 4 5 6
7

Similar funds

UOP
University of Pittsburgh Pittsburgh, Pennsylvania $135M AUM 29.36% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
ICM
Isabella Capital Management London $135M AUM
EC
Enhancing Capital Harrisburg, Pennsylvania $135M AUM 25.85% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
SA
Seneschal Advisors Tacoma, Washington $135M AUM 13.18% 1-Year Est. Return
JAA
Joel Adams & Associates Asheville, North Carolina $135M AUM 10.83% 1-Year Est. Return

Piper Sandler & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Piper Sandler & Co held 169 positions worth $93.5M, down 44% from $167M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Piper Sandler & Co withdrew a net $82.1M in Q3 2015, closing 63 positions and reducing 22 holdings. Its most notable exit was OMNICARE CAP TR II SER B 4% TR PFD INCM EQTY REDM SEC PIERS, an estimated $19.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 5.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Piper Sandler & Co opened a new position in vTv Therapeutics worth $5.05M.

  • Piper Sandler & Co's largest Q3 2015 buy was vTv Therapeutics: 19,381 shares worth $5.05M.
  • Piper Sandler & Co added most to Twitter, Inc. in Q3 2015, an estimated $150K increase.
  • Piper Sandler & Co's biggest Q3 2015 reduction was Direxion Daily Small Cap Bear 3x ETF, cutting an estimated $1.31M.
  • Piper Sandler & Co fully exited OMNICARE CAP TR II SER B 4% TR PFD INCM EQTY REDM SEC PIERS in Q3 2015, selling an estimated $19.6M.
  • Piper Sandler & Co's ten largest holdings make up 75% of its $93.5M portfolio in Q3 2015.
  • Piper Sandler & Co opened 71 new positions and closed 63 in Q3 2015.
  • Piper Sandler & Co's portfolio value fell 44% quarter-over-quarter to $93.5M.

Based on Piper Sandler & Co's 13F filing for Q3 2015, filed 16 Nov 2015.